ADVANCED MIC.DEV. DL-,01 | 69.48 / +5.15% |
News
- Apellis to Showcase Leadership in Retina at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
04/16/2021 / 18:44 - GlobeNewswire - Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at ARVO 2021
04/16/2021 / 14:05 - GlobeNewswire - AMD to Report Fiscal First Quarter 2021 Financial Results
04/15/2021 / 22:15 - GlobeNewswire - Dow closes above 34,000 pts, Nasdaq at record closing high
04/15/2021 / 22:01 - TeleTrader - Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
04/15/2021 / 14:00 - GlobeNewswire - CORSAIR Launches New AMD Ryzen™ 5000-Series Powered CORSAIR ONE a200 and 11th Gen Intel® Core™-Powered CORSAIR ONE i200 Gaming PCs
04/13/2021 / 15:00 - GlobeNewswire - Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy
04/13/2021 / 13:00 - GlobeNewswire - OXURION NV to Present at Wet AMD and DME Drug Development Summit
04/13/2021 / 07:30 - GlobeNewswire - AMD and Xilinx Stockholders Overwhelmingly Approve AMD’s Acquisition of Xilinx
04/07/2021 / 18:49 - GlobeNewswire - Oxurion NV – Publication in Progress in Retinal Eye Research highlights the potential of pan-RGD integrin antagonists to improve the treatment of diabetic retinopathy and wet AMD
04/07/2021 / 17:45 - GlobeNewswire - Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera
04/07/2021 / 07:00 - GlobeNewswire - ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision
04/06/2021 / 14:00 - GlobeNewswire - Opthea Company Secretary Resignation
04/06/2021 / 11:30 - GlobeNewswire - Oxurion NV enters into a Capital Commitment of up to €30 Million with Negma Group
04/06/2021 / 07:30 - GlobeNewswire - Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit
04/05/2021 / 13:05 - GlobeNewswire